Financial Navigation Study Among Young Adult Blood Cancer Survivors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-14

Study Completion Date

2023-11-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

NCT07281287

Oncology Financial Toxicity Counseling

RECRUITING NA

FINancial Toxicity and CAncer REcovery in YOUNG Adults

NCT07314801

Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults

ENROLLING_BY_INVITATION

Work Ability in Young Adult Cancer Survivors

NCT03148080

Cancer Survivor

COMPLETED

Symptom Management for YA Cancer Survivors

NCT04035447

Cancer Young Adult Pain +7 more

COMPLETED NA

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

NCT04960787

Hematopoietic and Lymphoid Cell Neoplasm Metastatic Malignant Solid Neoplasm Recurrent Malignant Solid Neoplasm

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This fully remote, multi-site study will evaluate the role of financial navigators in relieving financial distress in young adults (18-39y) who have completed treatment for blood cancer at least three years ago. Serial Assessments at study entry, 3-months, and 6-months measure financial distress measured using the study's primary outcome measure the Personal Financial Wellness Scale™ (PFW) (see below), hypothesized effect modifiers (emotional distress, self-efficacy, cognitive functioning), as well as care seeking, household finances and insurance characteristics. Randomization will occur following completion of baseline measures (see below for description of study arms). In addition to a formal evaluation of the intervention at 3- and 6-months, an optional interview will occur following the 6-month assessment/navigation intervention period to gain further insight from participants about the acceptability of the intervention. For ethical considerations related to the topic of study, all participants will be provided with the Leukemia \& Lymphoma Society's information specialist hotline.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Survivorship Cancer Financial Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

This is a multi-site, three-arm, financial navigation intervention

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

no blinding

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Navigation

Active navigation with the study-based financial navigator scheduling four check-in meetings throughout the study with the participant. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Group Type ACTIVE_COMPARATOR

Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

Intervention Type BEHAVIORAL

Providing financial navigation to blood cancer survivors.

Ad Hoc Navigation

Ad hoc navigation in which participant is provided study-based financial navigator to contact as needed. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Group Type ACTIVE_COMPARATOR

Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

Intervention Type BEHAVIORAL

Providing financial navigation to blood cancer survivors.

No study-based Navigation

No access to a study-based financial navigator, but access to a national hotline through the Leukemia \& Lymphoma Society. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Group Type ACTIVE_COMPARATOR

Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

Intervention Type BEHAVIORAL

Providing financial navigation to blood cancer survivors.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

Providing financial navigation to blood cancer survivors.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm)
2. Current age between 18-39 years old
3. Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood (18-36 years of age)
4. At least three years post blood cancer diagnosis
5. Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer medication with stable disease
6. Off treatment for a second cancer (non-blood cancer) or on a stable long-term regimen, such as hormone therapy or hormone replacement therapy
7. Primary residence in United States
8. Able to understand and read the English language